Cigna Group (CI) Aktievy
Cigna Group, tillsammans med sina dotterbolag, tillhandahåller försäkringar och relaterade produkter och tjänster i USA. Mer information
| Snöflinga Score | |
|---|---|
| Värdering | 5/6 |
| Framtida tillväxt | 1/6 |
| Tidigare resultat | 4/6 |
| Finansiell hälsa | 2/6 |
| Utdelningar | 5/6 |
Belöningar
Riskanalys
CI Community Fair Values
Create NarrativeSee what 95 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
The Cigna Group Konkurrenter
Prishistorik och prestanda
| Historiska aktiekurser | |
|---|---|
| Aktuell aktiekurs | US$290.58 |
| 52 veckors högsta | US$350.00 |
| 52 veckors lägsta | US$239.51 |
| Beta | 0.27 |
| 1 månads förändring | 8.93% |
| 3 månaders förändring | 6.01% |
| 1 års förändring | -13.31% |
| 3 års förändring | 19.24% |
| 5 års förändring | 13.10% |
| Förändring sedan börsintroduktionen | 4,905.21% |
Senaste nyheter och uppdateringar
Cigna Q1 Earnings Support A Higher Valuation
May 01
CI: Leadership Transition And Buybacks Will Drive Future Upside
Analysts have trimmed their average price target on Cigna Group by about $0.38 to roughly $338.42, reflecting small updates to fair value estimates, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News The Cigna Group plans a leadership transition, with current CEO David M.CI: Leadership Transition And Onsite Care Expansion Will Drive Future Upside
Analysts have slightly refined their view on Cigna Group, trimming the price target by a fraction to $338.79 as updated assumptions for revenue growth, profit margins, and future P/E bring the model into closer alignment with their latest expectations. What's in the News Cigna Group plans a leadership transition, with David M.CI: Onsite Care Expansion And Leadership Transition Will Support Future Upside
Analysts have nudged their fair value estimate for Cigna Group from about $336.67 to roughly $338.80. This reflects updated views on revenue growth, profit margins, and an anticipated forward P/E of around 13.43x.Recent updates
Cigna Q1 Earnings Support A Higher Valuation
May 01CI: Leadership Transition And Buybacks Will Drive Future Upside
Analysts have trimmed their average price target on Cigna Group by about $0.38 to roughly $338.42, reflecting small updates to fair value estimates, discount rate, revenue growth, profit margin, and future P/E assumptions. What's in the News The Cigna Group plans a leadership transition, with current CEO David M.CI: Leadership Transition And Onsite Care Expansion Will Drive Future Upside
Analysts have slightly refined their view on Cigna Group, trimming the price target by a fraction to $338.79 as updated assumptions for revenue growth, profit margins, and future P/E bring the model into closer alignment with their latest expectations. What's in the News Cigna Group plans a leadership transition, with David M.CI: Onsite Care Expansion And Leadership Transition Will Support Future Upside
Analysts have nudged their fair value estimate for Cigna Group from about $336.67 to roughly $338.80. This reflects updated views on revenue growth, profit margins, and an anticipated forward P/E of around 13.43x.CI: Onsite Care Expansion Will Support Future Upside Potential
Analysts now set Cigna Group's fair value estimate at about $336.67, up from roughly $332.62, reflecting updated assumptions that incorporate slightly higher revenue growth, profit margins, and a lower future P/E multiple. What's in the News Cigna Group plans a leadership transition, with CEO David M.CI: Higher Margin Outlook And Onsite Care Expansion Will Support Upside
Analysts have modestly lifted their price target on Cigna Group to $332.62 from $326.92, citing updated assumptions that combine slightly lower revenue growth with a higher profit margin and a future P/E of 15.62. What's in the News A class action lawsuit has been filed against Express Scripts, Cigna, and Evernorth, alleging a rebate diversion scheme that used an offshore entity, Ascent, to collect billions of dollars in kickbacks labeled as fees instead of passing rebates through to pharmacy benefit management clients, including the Plumbers' Welfare Fund.CI: Onsite Clinic And Stable Assumptions Will Support Future Upside
Analysts have kept their price target for The Cigna Group broadly unchanged at about US$327, citing only slight adjustments to revenue growth, profit margin and future P/E assumptions rather than any major shift in their outlook. What's in the News Hankook Tire America Corp.CI: Completed Buybacks And New Employee Clinic Will Support Future Upside
Analysts have nudged their fair value estimate for Cigna Group slightly higher to US$326.92 from US$325.57, citing minor refinements to discount rate assumptions, revenue growth expectations, profit margin inputs, and the forward P/E multiple used in their models. What's in the News Hankook Tire America Corp.CI: Massive Share Buyback And Clinic Expansion Will Support Future Earnings Upside
Analysts have slightly reduced their price target for Cigna Group, trimming fair value by about $0.69 to $325.57 as they factor in a more moderate revenue growth outlook, along with a small improvement in expected profit margins and future P/E assumptions. What's in the News Hankook Tire America Corp.CI: Massive Share Buyback Will Drive Future Earnings Upside Momentum
Narrative Update on Cigna Group Analysts have slightly lowered their price target on Cigna Group by approximately $2 to around $326 per share, reflecting modest tweaks to assumptions on long term growth, profitability, and valuation multiples, while maintaining a broadly constructive outlook. What's in the News Cigna Group reported that between July 1 and September 30, 2025, it repurchased no additional shares under its existing authorization, having already completed the buyback of about 133.5 million shares, or 41.09% of shares outstanding, for roughly $34.44 billion since the program was announced in December 2018 (company filing).CI: Massive Share Buyback Will Drive Future Earnings Upside Momentum
Analysts have raised their price target for Cigna Group to $328.35 per share, citing moderate adjustments to key financial metrics. These include a higher projected future price-to-earnings ratio and continued expectations for growth and profitability.CI: Significant Buybacks And 2026 Guidance Will Drive Upside Momentum
Narrative Update on Cigna Group Analysts have lowered their price target for Cigna Group from $349.04 to $328.35. This change reflects adjustments for a slightly higher discount rate as well as revised expectations for revenue growth and profit margins.CI: Share Repurchase Momentum Will Drive Long-Term Shareholder Value Creation
Analysts have lowered their price target for Cigna Group from $369.13 to $349.04. This change reflects updated expectations around modestly higher revenue growth, which are offset by a slight dip in profit margin projections.The Cigna Group (NYSE:CI) Screens Well But There Might Be A Catch
Jul 10
These 4 Measures Indicate That Cigna Group (NYSE:CI) Is Using Debt Reasonably Well
Jun 19We Think Cigna Group's (NYSE:CI) Robust Earnings Are Conservative
May 09The Cigna Group: Compelling Exposure To Diversified Healthcare At A Discount Price
Mar 31Cigna Is A Buy: Market Overreaction Creates A Big Opportunity
Feb 17Cigna: Buy The Drop On This Undervalued Growth Stock
Jan 18Cigna And The Risk Of PBMs - I'm Staying Out Above $230/Share
Dec 13Cigna: This Dividend Grower Could Be Worth Buying Now
Sep 26Cigna: Growth From Specialty Pharmacy And Care; Initiate With 'Buy'
Sep 19Cigna Group: Services Focus Leads To Outperformance
Jul 29Cigna: Game Over For PBMs?
Jul 12Cigna: Will Benefit From Lower Medicaid Enrollments
Jun 11Aktieägarnas avkastning
| CI | US Healthcare | US Marknad | |
|---|---|---|---|
| 7D | 3.9% | 3.8% | 0.6% |
| 1Y | -13.3% | -2.3% | 28.7% |
Avkastning vs industri: CI presterade sämre än US Healthcare branschen som gav -2.3 % under det senaste året.
Avkastning vs Marknaden: CI presterade sämre än US marknaden som gav 28.7 % under det senaste året.
Prisvolatilitet
| CI volatility | |
|---|---|
| CI Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 7.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.3% |
Stabil aktiekurs: CI har inte haft någon betydande prisvolatilitet under de senaste 3 månaderna jämfört med marknaden för US.
Volatilitet över tid: CI s veckovolatilitet ( 4% ) har varit stabil under det senaste året.
Om företaget
| Grundad | Anställda | VD OCH KONCERNCHEF | Webbplats |
|---|---|---|---|
| 1792 | 66,685 | David Cordani | www.thecignagroup.com |
Cigna Group, tillsammans med sina dotterbolag, tillhandahåller försäkringar och relaterade produkter och tjänster i USA. Verksamheten bedrivs genom två segment: Evernorth Health Services och Cigna Healthcare. Segmentet Evernorth Health Services omfattar Pharmacy Benefit Services och Specialty and Care Services, som erbjuder hantering av läkemedelsförmåner, hantering av läkemedelsanspråk, administration av apoteksnätverk, konsultation om förmånsutformning, granskning av läkemedelsanvändning, hantering av läkemedelslistor, apoteksförmåner, hemleveransapotek, specialapotek, distribution av specialläkemedel och kliniska program för att uppnå hälsoresultat för hela människan.
The Cigna Group Sammanfattning av grunderna
| CI grundläggande statistik | |
|---|---|
| Börsvärde | US$77.07b |
| Vinst(TTM) | US$5.96b |
| Intäkter(TTM) | US$274.90b |
Är CI övervärderat?
Se Verkligt värde och värderingsanalysResultat & intäkter
| CI resultaträkning (TTM) | |
|---|---|
| Intäkter | US$0 |
| Kostnad för intäkter | US$0 |
| Bruttovinst | US$0 |
| Övriga kostnader | US$0 |
| Intäkter | US$0 |
Senast redovisade vinst
Mar 31, 2026
Nästa vinstdatum
Jul 30, 2026
| Vinst per aktie (EPS) | 22.59 |
| Bruttomarginal | 9.30% |
| Nettovinstmarginal | 2.17% |
| Skuld/egenkapitalförhållande | 74.9% |
Hur har CI utvecklats på lång sikt?
Se historisk utveckling och jämförelseUtdelningar
Ger CI en tillförlitlig utdelning?
Se CI utdelningshistorik och jämförelsetal| Cigna Group datum för utdelning | |
|---|---|
| Ex utdelningsdag | Jun 04 2026 |
| Utbetalningsdag för utdelning | Jun 18 2026 |
| Dagar till Ex-utdelning | 33 days |
| Dagar till utdelningsdag | 47 days |
Ger CI en tillförlitlig utdelning?
Se CI utdelningshistorik och jämförelsetalFöretagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/04/30 11:29 |
| Aktiekurs vid dagens slut | 2026/04/30 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som användes för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och tutorials på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
The Cigna Group bevakas av 39 analytiker. 17 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| null null | Argus Research Company |
| Hua Ha | Baird |
| Joshua Raskin | Barclays |